Nerve Stimulator Reduced Chronic Pain and Healthcare Costs
A new study showed the Freedom Peripheral Nerve Stimulator system led to significant long-term patient improvements.
Updated on Sept. 28, 2026 in Arthritis
Live Poll
Do clinical studies on medical devices increase your trust in new treatments for chronic pain?
The journal Pain Physician published research finding the Freedom Peripheral Nerve Stimulator system helps patients manage chronic pain. Study participants experienced an 80% reduction in pain scores at 24 months, with improvements lasting through 36 months.
Why it matters
The study validates whether randomized controlled trial outcomes for neurostimulation technology successfully translate into real-world clinical practice. It also highlights potential shifts in how chronic pain is treated and how healthcare resources are utilized.
Patients reported an 80% reduction in pain scores after 24 months, while pain management interventions fell by 90%. Reductions in healthcare utilization included a 58.9% drop in office visits and a 58.8% decline in ambulatory surgery center visits.
The players
Pain Physician
This is a peer-reviewed medical journal that publishes research regarding pain management and interventional pain medicine.
Curonix
Headquartered in Pompano Beach, Florida, this medical technology company develops the Freedom Peripheral Nerve Stimulator system.
The details
The Freedom PNS system utilizes a two-component neurostimulator, an external transmitter, and specific software to deliver high-frequency electromagnetic coupling. The research analyzed outcomes for 175 patients in a retrospective review alongside 953 patients from a national claims database.
Timeline
September 28, 2026: The PNS IMPACT clinical study was published.
24 months: Reductions in pain scores and healthcare utilization were observed.
36 months: Durability of pain reduction was confirmed in study subjects.
The Big Picture
This research follows the findings established by the PNS IMPACT clinical study, which assessed the real-world efficacy of neurostimulation. It extends the conclusions of that program by providing supplemental claims data to support previous clinical trial results.
This study suggests that patients using the Freedom PNS system may experience significant, durable pain relief and require fewer medical interventions. Patients should discuss with their healthcare providers whether this neurostimulation technology is appropriate for their specific condition.
The takeaway
The study highlights that advanced neurostimulation systems may offer durable alternatives for chronic pain management while reducing the burden on clinical resources. Patients dealing with long-term pain should consult medical professionals about emerging technological interventions.
Further reading
Learn more about chronic pain management options in the United States Arthritis section.
More information
Review the full Freedom PNS System information and resources on the company's official website.
Source note: This article includes information reported by The Manila times.
Live Poll
Do clinical studies on medical devices increase your trust in new treatments for chronic pain?
